Immuto Scientific: Valuation, Funding & Investors
Immuto Scientific is pioneering advancements in target discovery by leveraging its AI-enabled structural surfaceomics platform to identify disease-specific structural changes in cell-surface proteins. The company focuses on developing first-in-class therapeutics with an initial emphasis on oncology, utilizing its proprietary technology to reveal novel, targetable surface protein conformations from patient-derived samples. Immuto's platform integrates high-resolution structural proteomics and advanced analytics to unlock new therapeutic opportunities across various diseases, enhancing the precision and safety of drug development.
Leadership & Board
Latest Estimated Valuation
- Total Amount Raised
- $8M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $8M
- Latest Funding Round
- Seed Round
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 18, 2025 | Seed Round | $8.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Great Oaks Venture Capital | Seed Round |
| WARF Ventures | Seed Round |
| DYDX | Seed Round |
| Gravity Fund | Seed Round |
Similar Companies
A snapshot of private companies similar to Immuto Scientific, helping you discover and navigate related company profiles.
Related News and Analysis
